EP3356825A4 - Detektion von mikrobiellen peptiden - Google Patents

Detektion von mikrobiellen peptiden Download PDF

Info

Publication number
EP3356825A4
EP3356825A4 EP16852182.1A EP16852182A EP3356825A4 EP 3356825 A4 EP3356825 A4 EP 3356825A4 EP 16852182 A EP16852182 A EP 16852182A EP 3356825 A4 EP3356825 A4 EP 3356825A4
Authority
EP
European Patent Office
Prior art keywords
detection
microbial peptides
microbial
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16852182.1A
Other languages
English (en)
French (fr)
Other versions
EP3356825A1 (de
Inventor
Agneta Richter Dahlfors
Andrew Benjamin LIBBERTON
Peter Nilsson
Marcus BÄCK
Susanne LÖFFLER
Hamid SHIRANI BIDABADI
Xiankeng CHOONG
Charalampos ANTYPAS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Life Science Development AB
Original Assignee
Richter Life Science Development AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Life Science Development AB filed Critical Richter Life Science Development AB
Publication of EP3356825A1 publication Critical patent/EP3356825A1/de
Publication of EP3356825A4 publication Critical patent/EP3356825A4/de
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/08Hydrogen atoms or radicals containing only hydrogen and carbon atoms
    • C07D333/10Thiophene
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10Complex mathematical operations
    • G06F17/18Complex mathematical operations for evaluating statistical data, e.g. average values, frequency distributions, probability functions, regression analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30Unsupervised data analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F16/00Information retrieval; Database structures therefor; File system structures therefor
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Data Mining & Analysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Computation (AREA)
  • Bioethics (AREA)
  • Mathematical Physics (AREA)
  • Mathematical Optimization (AREA)
  • Pure & Applied Mathematics (AREA)
EP16852182.1A 2015-10-01 2016-09-28 Detektion von mikrobiellen peptiden Pending EP3356825A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1551259 2015-10-01
PCT/SE2016/050919 WO2017058085A1 (en) 2015-10-01 2016-09-28 Detection of microbial peptides

Publications (2)

Publication Number Publication Date
EP3356825A1 EP3356825A1 (de) 2018-08-08
EP3356825A4 true EP3356825A4 (de) 2019-04-03

Family

ID=58423876

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16852182.1A Pending EP3356825A4 (de) 2015-10-01 2016-09-28 Detektion von mikrobiellen peptiden

Country Status (7)

Country Link
US (1) US11313859B2 (de)
EP (1) EP3356825A4 (de)
JP (1) JP6982319B2 (de)
CN (1) CN108369231A (de)
AU (1) AU2016331156B2 (de)
CA (1) CA3000625C (de)
WO (1) WO2017058085A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3888094A1 (de) * 2018-11-30 2021-10-06 Biofilm Control Verfahren zur detektion und überwachung der bildung von biofilmen
US20220154243A1 (en) * 2019-04-02 2022-05-19 National Institute For Materials Science Measurement apparatus, measurement method, program, and biosensor

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011039535A2 (en) * 2009-09-29 2011-04-07 King's College London Micellar compositions for use in biological applications
WO2011102789A1 (en) * 2010-02-16 2011-08-25 Oboe Ipr Ab Oligothiophene derivate as molecular probes
WO2013158550A1 (en) * 2012-04-15 2013-10-24 Theralase, Inc. Metal-based thiophene photodynamic compounds and their use
WO2014007730A1 (en) * 2012-07-02 2014-01-09 Richter Life Science Development Ab Carbohydrate detection
US20140273000A1 (en) * 2013-03-15 2014-09-18 Peter STYS Methods for analyzing blood to detect diseases associated with abnormal protein aggregation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660484B2 (en) 1992-11-13 2003-12-09 Regents Of The University Of California Colorimetric glycopolythiophene biosensors
ITBA20000020A1 (it) 2000-05-31 2001-12-01 Giovanna Barbarella Oligomeri del tiofene come marcatori fluorescenti ad alta efficienza per il riconoscimento e l'analisi quantitativa di molecole biologiche.
CA2442860C (en) * 2001-04-05 2011-02-01 Mario Leclerc Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives
WO2003029479A2 (en) * 2001-08-10 2003-04-10 Regents Of The University Of California Sensitive and rapid detection of pathogenic organisms and toxins using fluorescent polymeric lipids
BRPI0920850A2 (pt) 2008-10-17 2016-09-13 Biochromix Pharma Ab novos compostos e sua utilização
WO2012050645A2 (en) * 2010-06-25 2012-04-19 Purdue Research Foundation Pathogen detection
WO2013009259A1 (en) 2011-07-14 2013-01-17 Biochromix Pharma Ab Novel compounds and their use in therapy
WO2013036196A1 (en) 2011-09-07 2013-03-14 Biochromix Ab Novel thiophene compounds and method for in vivo imaging
WO2014125321A1 (en) 2013-02-15 2014-08-21 Ecole Normale Superieure De Lyon Multimodal agents for imaging
WO2017041051A1 (en) * 2015-09-04 2017-03-09 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011039535A2 (en) * 2009-09-29 2011-04-07 King's College London Micellar compositions for use in biological applications
WO2011102789A1 (en) * 2010-02-16 2011-08-25 Oboe Ipr Ab Oligothiophene derivate as molecular probes
WO2013158550A1 (en) * 2012-04-15 2013-10-24 Theralase, Inc. Metal-based thiophene photodynamic compounds and their use
WO2014007730A1 (en) * 2012-07-02 2014-01-09 Richter Life Science Development Ab Carbohydrate detection
US20140273000A1 (en) * 2013-03-15 2014-09-18 Peter STYS Methods for analyzing blood to detect diseases associated with abnormal protein aggregation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ABDELHAMID HANI NASSER ET AL: "Polymer dots for quantifying the total hydrophobic pathogenic lysates in a single drop", COLLOIDS AND SURFACES. B, BIOINTERFACES, vol. 115, 20 November 2013 (2013-11-20), pages 51 - 60, XP028836502, ISSN: 0927-7765, DOI: 10.1016/J.COLSURFB.2013.11.013 *
ANDREAS Ã SLUND ET AL: "Novel Pentameric Thiophene Derivatives for in Vitro and in Vivo Optical Imaging of a Plethora of Protein Aggregates in Cerebral Amyloidoses", ACS CHEMICAL BIOLOGY,, vol. 4, no. 8, 21 August 2009 (2009-08-21), pages 673 - 684, XP009169366, ISSN: 1554-8929, [retrieved on 20090722], DOI: 10.1021/CB900112V *
MARIE-PIER PLANTE ET AL: "Polythiophene Biosensor for Rapid Detection of Microbial Particles in Water", ACS APPLIED MATERIALS & INTERFACES, vol. 5, no. 11, 12 June 2013 (2013-06-12), US, pages 4544 - 4548, XP055386470, ISSN: 1944-8244, DOI: 10.1021/am400162h *

Also Published As

Publication number Publication date
AU2016331156A1 (en) 2018-04-26
AU2016331156B2 (en) 2022-03-03
US20180275125A1 (en) 2018-09-27
JP6982319B2 (ja) 2021-12-17
JP2018537070A (ja) 2018-12-20
EP3356825A1 (de) 2018-08-08
CA3000625A1 (en) 2017-04-06
CN108369231A (zh) 2018-08-03
WO2017058085A1 (en) 2017-04-06
US11313859B2 (en) 2022-04-26
CA3000625C (en) 2024-02-13

Similar Documents

Publication Publication Date Title
EP3347035A4 (de) Auf knorpel abzielende peptide
EP3317632A4 (de) Leckdetektionssystem
EP3335154A4 (de) Verfolgungssensor
EP3191599A4 (de) Detektion von fehlgefalteten proteinen
EP3194422A4 (de) Antimikrobielle peptide
EP3108707A4 (de) Näherungsdetektor
EP3622431A4 (de) Erkennung von beeinträchtigungen einer krypto-ransomware
EP3096616A4 (de) Antimikrobielle peptide vom dermaseptintyp und piscidintyp
EP3170119A4 (de) Detektion der stapelpivotisierung
EP3148327A4 (de) Schädlingserkennung
EP3371741A4 (de) Fokusdetektion
EP3361492A4 (de) Detektionselement
EP3215172A4 (de) Modifikationen und verwendungen von conotoxin-peptiden
EP3697499A4 (de) Nachweis von symmetrischem dimethylarginin
EP3280821A4 (de) Nachweis eines oder mehrerer krankheitserreger
EP3218888A4 (de) Bahnerkennung
EP3183362A4 (de) Elektrochemischer nachweis von mikroorganismen
EP3266794A4 (de) Peptid
EP3197921A4 (de) Statherinpeptide
EP3143050A4 (de) Strichcodierte peptide
EP3380115B8 (de) Peptide aus piwil1
EP3387627A4 (de) System zur erkennung mehrerer gefahren
EP3385744A4 (de) Positionserkennungssystem
EP3347477A4 (de) Zusammensetzungen und verfahren zum proteinnachweis
EP3155133A4 (de) Wachstumsunabhängiger nachweis von zellen

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180427

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20190228

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 333/10 20060101ALI20190222BHEP

Ipc: G01N 33/569 20060101AFI20190222BHEP

Ipc: G01N 33/58 20060101ALI20190222BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20200721

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS